Greenleaf Trust boosted its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 0.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,477 shares of the business services provider’s stock after buying an additional 14 shares during the period. Greenleaf Trust’s holdings in Stericycle were worth $800,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its stake in shares of Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock worth $421,877,000 after buying an additional 4,947,900 shares during the period. Ameriprise Financial Inc. raised its stake in Stericycle by 144.9% in the first quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock worth $157,594,000 after buying an additional 1,124,908 shares during the last quarter. Wedge Capital Management L L P NC acquired a new stake in Stericycle during the first quarter worth about $43,949,000. Wells Fargo & Company MN raised its stake in Stericycle by 25.5% in the first quarter. Wells Fargo & Company MN now owns 1,956,193 shares of the business services provider’s stock worth $162,149,000 after buying an additional 398,076 shares during the last quarter. Finally, Jennison Associates LLC raised its stake in Stericycle by 32.7% in the first quarter. Jennison Associates LLC now owns 1,417,498 shares of the business services provider’s stock worth $117,496,000 after buying an additional 349,371 shares during the last quarter. 94.56% of the stock is owned by hedge funds and other institutional investors.
Shares of Stericycle, Inc. (NASDAQ:SRCL) traded up 1.18% on Monday, reaching $71.87. 488,355 shares of the company’s stock were exchanged. The company’s market cap is $6.13 billion. Stericycle, Inc. has a 12 month low of $70.24 and a 12 month high of $88.00. The firm’s 50-day moving average price is $76.45 and its 200 day moving average price is $80.44.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The firm had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. During the same quarter in the prior year, the business posted $1.18 EPS. The business’s revenue was up 2.9% compared to the same quarter last year. Equities research analysts predict that Stericycle, Inc. will post $4.60 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://stocknewstimes.com/2017/08/14/greenleaf-trust-acquires-14-shares-of-stericycle-inc-nasdaqsrcl-updated-updated.html.
Several brokerages recently issued reports on SRCL. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the stock a “buy” rating in a report on Saturday, May 6th. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a report on Tuesday, April 25th. Robert W. Baird lowered Stericycle from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $74.00 to $73.00 in a report on Friday, May 5th. Deutsche Bank AG lowered their target price on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, May 15th. Finally, BMO Capital Markets began coverage on shares of Stericycle in a research report on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price on the stock. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $81.15.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
